Tourmaline Bio added to the NASDAQ Biotechnology Index

NEW YORK, Dec. 15, 2023 -- Tourmaline Bio, Inc. , a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering...

Related Keywords

,Nasdaq ,Tourmaline Bio Inc ,Nasdaq Stock ,Industry Classification ,Tourmaline Bio ,Thyroid Eye Disease ,